Table 4 Details of 6 patients who died... | American Society of Hematology

Table 4

Details of 6 patients who died due to hepatic failure

Case	Age, y	Sex	Stage	Treatment	Hepatic disease at baseline	AST/ALT, IU/L		HCV-RNA, KIU/mL
Case	Age, y	Sex	Stage	Treatment	Hepatic disease at baseline	At baseline	Peak level	At baseline	Peak level during treatment
1	75	M	I	RCEOP	LC	91/63	136/102	ND	1000
2	74	F	IV	RTHPCOP	HCC	29/16	58/49	4400	5000
3	68	F	II	RTHPCOP	CH	118/76	203/113	510	1600
4	71	F	III	RCHOP	HCC	34/41	242/139	470	ND
5	64	M	IV	RCHOP	HCC	27/10	97/32	ND	ND
6	76	M	III	RTHPCOP	HCC	46/40	111/107	434	21 300

Case	Age, y	Sex	Stage	Treatment	Hepatic disease at baseline	AST/ALT, IU/L		HCV-RNA, KIU/mL
Case	Age, y	Sex	Stage	Treatment	Hepatic disease at baseline	At baseline	Peak level	At baseline	Peak level during treatment
1	75	M	I	RCEOP	LC	91/63	136/102	ND	1000
2	74	F	IV	RTHPCOP	HCC	29/16	58/49	4400	5000
3	68	F	II	RTHPCOP	CH	118/76	203/113	510	1600
4	71	F	III	RCHOP	HCC	34/41	242/139	470	ND
5	64	M	IV	RCHOP	HCC	27/10	97/32	ND	ND
6	76	M	III	RTHPCOP	HCC	46/40	111/107	434	21 300

ND indicates not done.